| Systematic (IUPAC) name | |
|---|---|
| 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a601049 |
| Pregnancy cat. | To be avoided within two months of term |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Pharmacokinetic data | |
| Excretion | Excreted unchanged in urine |
| Identifiers | |
| CAS number | 127-69-5 |
| ATC code | J01EB05 S01AB02 QJ01EQ05 |
| PubChem | CID 5344 |
| DrugBank | APRD00595 |
| UNII | 740T4C525W |
| KEGG | D00450 |
| ChEMBL | CHEMBL453 |
| Chemical data | |
| Formula | C11H13N3O3S |
| Mol. mass | 267.30 g/mol |
| SMILES | eMolecules & PubChem |
| (what is this?) (verify) |
|
Sulphafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin or phenazopyridine. It is used locally in a 4% solution or ointment.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||